Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
GLP-1 Medications is administered as a subcutaneous injection once a week
Can Akkermansia support GLP-1 therapy outcomes
Beyond weight reduction, the same trial reported several additional metabolic outcomes as secondary or exploratory endpoints: Improved glycaemic control reductions in HbA1c levels were observed in participants with type 2 diabetes in a separate Phase 2 cohort [3] [4] Reduced waist circumference suggesting a decrease in visceral (abdominal) fat, which is associated with cardiovascular risk Improvements in lipid profiles including reductions in triglycerides Potential signal for benefit in metabolic-associated steatotic liver disease (MASLD) based on the glucagon receptor's proposed role in hepatic fat metabolism
We dont want kids losing muscle mass or bone mass at an early age because that will set them up with issues potentially with osteoporosis in the future. Studies have shown GLP-1s can reduce bone mass along with overall weight loss
Additionally, it has shown improvements in blood pressure, lipid profiles, and blood sugar
The Recommended Dietary Allowance is 400-420 mg daily for adult men and 310-320 mg for adult women from all sources
